Tekla Life Sciences Investors (HQL) Company Profile

Tekla Life Sciences Investors Company Snapshot

Tekla Life Sciences Investors operates in the Investment offices sector. In addition to historical fundamental analyses, the complete report available to purchase compares Tekla Life Sciences Investors with three other companies in this sector in UNITED STATES : Invesco Advantage Municipal Income Trust II (2020 sales of $36.85 million ), Gladstone Capital Corporation ($39.07 million of which 100% was Investment Income), and BlackRock Municipal Income Trust ($36.87 million ).

Sales Analysis. Tekla Life Sciences Investors reported sales of $39.07 million for the fiscal year ending September of 2020. This represents a decrease of 0.0% versus 2019, when the company's sales were $39.09 million.

Tekla Life Sciences Investors

Stock Data:

Recent Stock Performance:

Current Price (2/26/2021): 20.89
(Figures in U.S. Dollars)

1 Week	-5.3%	13 Weeks	2.9%

4 Weeks	11.5%	52 Weeks	31.5%

Tekla Life Sciences Investors Key Data:

Ticker:	HQL	Country:	United States

Exchanges:	NYSE	Major Industry:	Diversified Financials

		Sub Industry:	Investment Offices

2020 Sales	39,071,648 (Year Ending Jan 2021).	Employees:	N/A

Currency:	U.S. Dollars	Market Cap:	498,919,045

Fiscal Yr Ends:	September	Shares Outstanding:	23,883,152

Share Type:		Closely Held Shares:	580

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.